View our list of available Coronavirus (COVID-19, SARS-CoV-2, 2019-nCOV) antibodies, recombinant proteins, ELISA Kits... Options Full Datasheet Printer Friendly Datasheet Prepare for Printing Full Datasheet Printer Friendly Datasheet Prepare for Printing Have Questions? Ask Us! Request A Quote Today! Add To Compare List HAV P2C recombinant protein :: Hepatitis A Virus P2C Recombinant Protein Catalog # MBS142498 Unit / Price 0.1 mg / $335 +1 FREE 8GB USB 0.5 mg / $830 +1 FREE 8GB USB 1 mg / $1,265 +1 FREE 8GB USB 5x1 mg / $5,355 +6 FREE 8GB USB Product Name Product Info Accession #s Product Desc Diseases/Tissues/Pathways Applications References Product Name Hepatitis A Virus P2C (HAV P2C ), Recombinant Protein Full Product Name Recombinant Hepatitis A Virus P2C Product Synonym Names HAV P2C; Hepatitis A Virus P2C Recombinant Product Gene Name HAV P2C recombinant protein[Similar Products] Research Use Only For Research Use Only. Not for use in diagnostic procedures. TOP Specificity Immunoreactive with sera HAV-infected individuals. Purity/Purification Protein is >90% pure as determined by 10% PAGE (coomassie staining).HAV P2C protein was purified by proprietary chromatographic technique. Form/Format 10mM CBB, pH9.6, 0.1% SDS and 50% glycerol. Other Notes Small volumes of HAV P2C recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply. TOP Related Product Information for HAV P2C recombinant protein Description: The E Coli derived recombinant 38.5 kDa protein contains the P2C immunodominant regions, amino acids 1121-1234.Introduction: Forty-two antigenic domains were identified across the hepatitis A virus (HAV) polyprotein by using a set of 237 overlapping 20-mer synthetic peptides spanning the entire HAV polyprotein. Nineteen antigenic domains were found within the structural proteins, and 22 were found within the nonstructural proteins, with 1 domain spanning the junction of VP1 and P2A proteins. Five of these domains were considered immunodominant, as judged by both the breadth and the strength of their immunoreactivity. One domain is located within the VP2 protein at position 57-90 aa. A second domain, located at position 767-842 aa, contains the C-terminal part of the VP1 protein and the entire P2A protein. A third domain, located at position 1403-1456 aa, comprises the C-terminal part of the P2C protein and the N-terminal half of the P3A protein. The fourth domain, located at position 1500-1519 aa, includes almost the entire P3B, and the last domain, located at position 1719-1764 aa, contains the C-terminal region of the P3C protein and the N-terminal region of the P3D protein. Four of the five most immunoreactive domains are derived from small HAV proteins and/or encompass protein cleavage sites separating different HAV proteins. Product Categories/Family for HAV P2C recombinant protein Viral Antigens; HEPATITIS A VIRUS; Viral Antigens; Hepatitis A Applications Tested/Suitable for HAV P2C recombinant protein ELISA (EIA), Western Blot (WB) Application Notes for HAV P2C recombinant protein HAV P2C antigen is suitable for ELISA and Western blots, excellent antigen for detection of HAV with minimal specificity problems. TOP Precautions All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines. Disclaimer While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information. TOP